---
trial_id: 1545
discovery_date: 2022-07-29 15:03:31.682213
date: 2022-07-29 15:03:31.682213
title: "A double-blind, placebo controlled multicentre study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis."
summary: |
  <p>EudraCT Number: 2004-002571-16<br />Sponsor Protocol Number: MBP8298-01 Amendment 04<br />Sponsor Name: BioMS Technology Corp<br />Start Date: 2007-06-29<br />Medical condition: Secondary progressive multiple sclerosis<br />Disease: <br />Version: 8.1<br />SOC Term: <br />Classification Code: 10063400<br />Term: Secondary progressive multiple sclerosis<br />Level: LLT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/FI">FI</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/DK">DK</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/EE">EE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/NL">NL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/LT">LT</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/LV">LV</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-002571-16'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2004-002571-16<br />Sponsor Protocol Number: MBP8298-01 Amendment 04<br />Sponsor Name: BioMS Technology Corp<br />Start Date: 2007-06-29<br />Medical condition: Secondary progressive multiple sclerosis<br />Disease: <br />Version: 8.1<br />SOC Term: <br />Classification Code: 10063400<br />Term: Secondary progressive multiple sclerosis<br />Level: LLT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/FI">FI</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/DK">DK</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/EE">EE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/NL">NL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/LT">LT</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002571-16/LV">LV</a> (Completed)</p>